Could you highlight how you will analyse the data from your whole-genome sequencing studies of Brugada syndrome? RR:

Research on the genetics of cardiac disorders began at Nantes University Hospital in the mid-1990s, when Chief Cardiologist Professor Hervé Le Marec and I identified a new susceptibility locus for the Long QT syndrome. In 1998, the French Institute of Health and Medical Research (Inserm) appointed me to join Professor Denis Escande’s laboratory in Nantes and further develop research on the genetics of cardiac arrhythmias with the notable support of the Alliance Against Sudden Cardiac Death (SDC), a former transatlantic Network of Excellence funded from 2006 to 2011 by the Leducq Foundation.